[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584862":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":11,"centralContacts":34,"locations":42,"responsibleParty":62,"collaborators":64,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":11,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":11,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":94,"overallStatus":45,"whyStopped":11,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Nuritas Ltd","INDUSTRY",[8,14,17,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Lentil protein hydrolysate 500 mg\u002Fday","EXPERIMENTAL",null,[13],"Dietary Supplement: Lentil protein hydrolysate",{"label":15,"type":10,"description":11,"interventionNames":16},"Lentil protein hydrolysate 1000 mg\u002Fday",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Lentil protein hydrolysate 2000 mg\u002Fday",[13],{"label":21,"type":22,"description":11,"interventionNames":23},"Microcrystalline Cellulose 2000mg\u002Fday","PLACEBO_COMPARATOR",[24],"Dietary Supplement: Placebo MCC micro-crystalline cellulose",[26,31],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":11},"DIETARY_SUPPLEMENT","Lentil protein hydrolysate","Plant protein hydrolysate",[15,18,9],{"type":27,"name":32,"description":32,"armGroupLabels":33,"otherNames":11},"Placebo MCC micro-crystalline cellulose",[21],[35,40],{"name":36,"role":37,"phone":38,"phoneExt":11,"email":39},"Niamh M Mohan, PhD","CONTACT","+353 1 430 1290","mohan.niamh@nuritas.com",{"name":41,"role":37,"phone":38,"phoneExt":11,"email":11},"Brian Keogh, Phd",[43],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Baker Heart and Diabetes Institute","RECRUITING","Melbourne","Victoria","3004","Australia","AU",{"type":52,"coordinates":53},"Point",[54,55],144.96332,-37.814,{"lat":55,"lon":54},[58],{"name":59,"role":37,"phone":60,"phoneExt":11,"email":61},"Erin Howden, Phd","+61 3 8532 1800","Erin.Howden@baker.edu.au",{"type":63,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[65,68],{"name":66,"class":67},"Australian Catholic University","OTHER",{"name":44,"class":67},"100584862","effects-of-lentil-protein-hydrolysate-on-blood-pressure-control-vascular-function-and-exercise-performance-100584862",false,"NCT06894875","Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance","Examining the Safety and Tolerability of Lentil Protein Hydrolysate in Healthy Males and Females Whilst Exploring the Effects of a Dose Range on Blood Pressure Control and Vascular Function and Exercise Performance","Inclusion Criteria:\n\n* Willing to provide written and dated informed consent to participate in the study.\n* Willing and able to comply with the protocol.\n* Are not on any medication, or supplements which would impact the trial in the opinions of the investigator or Sponsor.\n* Male or female between 18 and 45 years of age (18.5 kg\u002Fm2 ≥ BMI \\\u003C 30 kg\u002Fm2).\n* Comply with ACSM guidelines for physical activity.\n* Have not participated in a clinical trial within the past month and agree to not participate in another clinical trial during the study period.\n* Agree to not significantly alter diet or exercise routine during the trial period.\n* Willing to wear a wearable device continuously for the duration of the study\n\nExclusion Criteria:\n\n* Subjects having a known allergy or hypersensitivity to any of the ingredients in the investigational products.\n* Subjects with a history of alcohol and\u002For other drug abuse in the past year.\n* Has performed strenuous exercise (rating of perceived exertion ≥ 13) ≤ 48 hours before laboratory visit (Borg, 1982).\n* Consuming \\>14 alcoholic drinks per week or \\> 2 drinks\u002Fday in the 48 hours preceding a clinic visit.\n* Active smokers, nicotine use or vaping\n* Subjects suffering from a sleep disorder and\u002For who have a known history of (or was being treated for) clinical depression, eating disorder(s) or any other psychiatric condition(s) that might put the subject at risk and\u002For confounded the results of the study.\n* Subjects with a history of being diagnosed with phenylketonuria or another disease affecting amino acid metabolism (i.e., maple syrup urine disease, etc.).\n* Subjects with an elevated resting heart rate (\\>100 bpm) or blood pressure (systolic BP \\>140 mmHg or diastolic BP \\>90 mmHg).\n* Pregnant or lactating women\n* Presentation of orthostatic hypotension during the screening and familiarisation study visit\n* Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion.",true,"ALL","18 Years","45 Years",{"count":81,"type":82},48,"ESTIMATED","INTERVENTIONAL",[85],"NA","Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance",[88,89,90,91,92,93],"Exercise","Blood Pressure","Vasodilation","Vascular Function in Healthy Volunteers","Exercise Performance","Safety and Tolerability in Healthy Volunteers",[95,96,97,28],"Exercise performance","Vascular function","blood pressure control","2025-12-15",{"date":100,"type":101},"2025-12-16","ACTUAL",{"date":103,"type":101},"2025-06-24",{"date":105,"type":82},"2026-03-30",{"name":5,"class":6},1]